Macrophage-dependent killing of facultative intracellular bacteria was markedly impaired by overt erythrocytic Plasmodium yoelii or Plasmodium berghei infection of mice. P. yoelii infection was capable of ablating not only the macrophage microbicidal capacity of "normal" animals but also the bactericidal capacities of "activated" macrophages. The uptake by spleen and liver of an intravenous challenge of Listeria monocytogenes was not altered by plasmodial infection, but within hours of injection markedly enhanced bacterial growth was found in tissues of malarious mice. The evidence gives credence to the view that the uptake of bacteria by macrophages of malarious mice was normal but that malarious mice, unlike normal mice, were unable to kill the bacteria. The plasmodial infectioncaused defect in macrophage microbicidal capacity could be partially mimicked by the intravenous injection of large numbers of nonreplicating heterologous particles (i.e., killed bacteria, sheep erythrocytes). This result suggests that the uptake of particles generated during overt erythrocytic malaria may be responsible for the malaria-associated defects in macrophage bactericidal capacity.
It is clear that the murine response to plasmodial infections includes the production of an enlarged population of phagocytic cells (30, 50, 56) . It seems reasonable, therefore, to suggest that these cells might be produced in order to aid in the defense against malaria. However, with the exception of the recent demonstration of a cytophilic antibody (16) which might work in concert with macrophages in clearing Plasmodium berghei infection of rats, there is no direct evidence of a phagocytic cell-mediated restriction of plasmodial infection. There is indirect evidence which might be interpreted to support a protective role for these cells in ma- laria. This evidence includes demonstration of enhanced phagocytic capacities (4, 21, 24, 47) during malaria, the finding by histological techniques of parasitized (and nonparasitized) erythrocytes (RBC) in phagocytic vacuoles of infected animals (3, 51, 58) , and the demonstrations that in vitro macrophages from P. berghei-infected mice have an enhanced capacity to phagocytize reticulocytes (48) and that in vitro under certain conditions immune sera opsonize plasmodia (2, 6, 16, 17, 57) . The demonstration that intravenous inoculations of carbon particles or thorium dioxide (15) (materials which may cause a reticuloendothelial cell blockade) cause a potentiation of P. berghei infection in mice and the demonstration that injections of agents such as Corynebacterium parvum (8) and Mycobacterium bovis which can cause activation of macrophages (7) may nonspecifically protect against some plasmodial parasites also indirectly indicate a role for the macrophages in the control of plasmodial infection.
However, a substantial body of evidence has been presented which demonstrates that the macrophages of malarious animals are defective with respect to certain functional capacities. Thus, fixed phagocytic cells appear to be functionally compromised by malaria in that endotoxin detoxification capacity is markedly reduced (25) , test lipids are not effectively cleared from blood (21) , and processing or presentation of thymus-dependent antigens is aberrant (53, 54) ; furthermore, in this laboratory (32) it was found recently that macrophage bactericidal capacities are lost. It appears, therefore, that the host may respond to plasmodial infection by generating an enlarged population of phagocytic cells but that the plasmodia may in turn cause disturbances in phagocyte function. The mechanism(s) of these plasmodia-induced disturbances in macrophage function and the significance of these defects to the quality of the host defense to malaria remain to be discovered.
The purpose of this study was to further characterize the plasmodia-caused defect in macrophage microbicidal activities described previously (32) . The results show that this defect is of substantial magnitude, compromises the host's capacity to deal with at least three genera of facultative intracellular bacteria, and may be 396 on November 6, 2017 by guest http://iai.asm.org/ Downloaded from mediated by malaria infection-caused bombardment of fixed phagocytes with particulate materials perhaps in a manner similar to the phenomenon of reticuloendothelial cell blockade.
MATERIALS AND MErHODS Animals. Female mice of the randomly bred ICR strain, syngeneic A strain, and syngeneic F1 hybrid B6D2 (C57BL/6 x DBA/2) strain were obtained when they were 5 to 8 weeks old from colonies maintained at the Trudeau Institute or the University ofMaryland School of Medicine. The mice were provided with water and a standard diet (4RF, Charles River formula; Agway, Waverly, N.Y.) ad libitum.
Plasmodia. P. berghei strain NYU-2, Plasmodium yoelii strain 17X, and Plasmodium chabaudi were used. The source and procedures used for maintenance of P. berghei (33) and P. yoeiii (32) Bacteria. Listeria monocytogenes (strain EGD), Salmonella enteritidis (strain 5694), and Yersina enterocolitica (strain WA) were used. The L. monocytogenes was from the same frozen seed used for a previous study (32 Statistics. The statistical significance of differences between treated and control groups was determined either by the t test or, when more than two groups were tested, by analysis of variance and Tukey's test.
Assay of systemic macrophage bactericidal activity. Changes in macrophage-mediated bactericidal activity were measured by comparing the growth of an intravenous challenge of facultative intracellular bacteria in experimentally manipulated mice with the growth of bacteria from the same inoculum delivered to normal mice. The recovery of fewer bacteria from treated than from control mice was evidence of activation of microbicidal capacity, whereas the recovery of greater numbers of bacteria from treated animals was evidence of a loss of macrophage bactericidal capacity. This is an established procedure for determining levels of macrophage microbicidal activities and is discussed elsewhere (32, 40, 41 (44) . RESULTS Subversion of systemic macrophage microbicidal capacities by P. yoelii infection. lenge with 105 CFU of L. monocytogenes was markedly reduced. This was evidenced on days 7 and 14 after plasmodial infection by a marked increase in the growth of bacteria in liver and spleen.
No relationship between level of suppression of macrophage microbicidal capacities as measured in liver and spleen and the ultimate outcome of the malaria infection was established. Rather, overt P. yoelii infection essentially ablated macrophage microbicidal capacity in these organs.
To establish that the changes in macrophage function recorded in Fig. 1 resulted from P. yoelii infection and not from the introduction of heterogeneic cells or plasma, RBC were collected from a normal ICR mouse, and a number of these cells equivalent to the number delivered at the initiation of P. yoelii infection was inoculated into naive recipients. These animals were challenged with L. monocytogenes at 10 mi or 7 or 14 days. No evidence of defective macrophage bactericidal function was found.
Most of the studies presented below were conducted on day 14 of P. yoelii infection at about the peak of parasitemia and at the time of the maximum defect in macrophage microbicidal function. No attempt is made to separately present data generated from mice which would die of P. yoelii, because these could not be identified at day 14. Mice died of P. yoelii infection from as early as day 12 through as late as day 28 (most died between 17 and 21 days).
To determine whether the capacity of macrophages to kill bacteria other than L. monocytogenes was suppressed by murine malaria, mice were challenged intravenously with 10' CFU of either L. monocytogenes, S. enteritidis, or Y. enterocolitica. Twenty-four hours after bacterial challenge, these mice were sacrificed, and the number of organisms in liver was determined. These bacteria were chosen for this study because it has been established (5, 37, 41) that a large number of the intravenously inoculated organisms are apparently killed by liver macrophages. Figure 4 shows significant levels of suppression of microbicidal function in P. yoelii-and P. berghei-infected animals. P. chabaudi infection, however, did not cause a similar defect.
Changes in antibacterial resistance reflect a lo0s of preexisting macrophage bactericidal capacity. It is established that in vivo killing of L. monocytogenes is effected by macrophages (26, 27, 35) . The level of bactericidal activities of these cells is in turn modulated by lymphoid cells (27, 29, 36 fore, that the loss of macrophage bactericidal capacities observed in the foregoing experiments might have resulted from a plasmodial infectioninduced defect in macrophages or, alternatively, from a defect in the capacity of malarious mice to generate those lymphoid cells which modulate macrophage bactericidal activities.
To determine which of these groups of lesions was responsible for the loss of microbicidal capacities during P. yoelii infection, advantage was taken of the demonstration by North et al. (41) that macrophages of normal animals rapidly destroy the majority of the inoculated L. monocytogenes within 8 to 12 h after bacterial challenge. It was predicted that if P. yoelii directly modified macrophage function, then the fate of L.
monocytogenes within the first 12 h would differ for malarious and normal mice. Alternatively, if P. yoelii caused a lesion in the generation of specifically sensitized anti-L. monocytogenes lymphoid cells, it might be expected that the fate of the bacteria during the first 12 h after inoculation would be similar for normal and malarious mice but that subsequently the failure of the malarious animals to generate or deploy specific lymphoid cells in response to L. monocytogenes, a process which requires days (36), would be reflected in differences in the later phase of the L. monocytogenes infection.
It can be seen in Fig. 5 that mice challenged with L. monocytogenes 10 min after P. yoelii infection, at a time when macrophage microbicidal capacities were previously shown to be near normal (see Fig. 1 Figure 6 shows, as expected (1, 23) , that mice infected with BCG alone had activated macrophages, as evidenced by enhanced levels of listericidal capacity as compared to normal animals. By contrast, BCG-infected animals subsequently infected with P. yoelii showed a marked suppression of microbicidal ability. The magnitude of the defect was demonstrated by the recovery of 10,000-fold more L. monocytogenes from BCG + P. yoelii-infected animals than from mice infected with BCG alone. Figure 6B shows that levels of P. yoelii infection were similar in BCG-infected and in otherwise normal mice. Figure 6C presents the numbers of BCG recovered from the liver of P. yoelii-infected and control mice which 22 with specific cellular immuiity. However, because it requires 10 to 15 days for mice to acquire, after intravenous injection of BCG, a capacity to control bacterial growth in liver and spleen (1) and because in the previous experiment P. yoelii infections were initiated on day 7 of BCG infection, it was not possible to determine whether the plasmodial infection interfered with the expression of an established state of cellular immunity. Alternatively, P. yoelii might have prevented the development of the cellular defense.
To determine whether P. yoelii infection could interfere with the expression of an established state of cellular immunity, advantage was taken of the demonstration by Mackaness (26) that an immunizing infection with L. monocytogenes is followed by a long-lived state of To establish a long-lived state of cellular resistance to L. monocytogenes, mice were inoculated intravenously with 103 CFU. Twenty-eight days later, when the bacteria had been cleared and, as has been shown by others, a population of nondividing T cells with anti-L. monocytogenes potential had been established (26, 37, 39) , a subset of the L. monocytogenes-immune mice were infected with P. yoelii. Either 10 min or 14 days later, groups of these mice and controls were challenged with L. monocytogenes.
Mice immune to L. monocytogenes were better able to resist bacterial challenge than nonimmune controls (Fig. 7A ). This increased resistance was manifested as an accelerated capacity to generate a defense and not as an enhanced level of bacterial killing during the first 6 to 12 h after challenge. Therefore, this enhanced resistance has characteristics of immunological memory (37, 39) .
Mice infected with P. yoelii 10 min before L. monocytogenes challenge showed the same pattern of bacterial infection as the respective controls. Thus, it is apparent that levels of malaria infection that do not cause a loss of nonspecific macrophage bactericidal capacities (Fig. 1 Figure 8 shows the result of an experiment in which mice were inoculated with a variety of nonliving particles and challenged 3 h later with L. monocytogenes. It can be seen in this figure that recipients of particles were substantially compromised in their capacity to kill L. monocytogenes as compared with normal mice or recipients of the diluent (0.15 M NaCl). Figure 9 shows that the level of suppression of microbicidal activities was directly related to the number of heterologous particles inoculated. Mice inoculated with either sheep RBC or killed L. monocytogenes and challenged with live L. monocytogenes 3 h later failed to kill the bacteria during the first 12 h after challenge to the extent that control animals did (Fig. 10) .
To determine the duration of the particleinduced lesion in bactericidal activities, mice were inoculated with 1010 killed L. monocytogenes cells or 109 sheep RBC and challenged at intervals from 3 h through 48 h thereafter with live L. monocytogenes. Suppression of this capacity was transient, with the maximal defect occurring at 6 h and normal macrophage bactericidal activity returning by day 2 (Fig. 11) .
before an intravenous challenge with 105 CFU of L. monocytogenes. Livers were collected 24 h later from each of the groups and from otherwise untreated L. monocytogenes-infected mice. Each ofthe groups pretreated with particulate materials showed significantly more (P 5 0.01, indicated by *) L. monocytogenes cellsper liver than control mice which received L. monocytogenes infection only. 
DISCUSSION
Mice can be partially protected from erythrocytic-stage P. berghei (31, 55) or P. yoelii (32, 42, 46) infection by the passive transfer of immune serum. However, recipients of immune serum do not usually exhibit a quality of immunity similar to that exhibited by a mouse which has recently recovered from a plasmodial infection (31, 42) . Thus, the possibility that a Tcell-mediated cellular defense may work in concert with antibody in clearing plasmodial infections must be considered. This possibility receives indirect support from (i) observations which show that delayed footpad swelling reactions to injections of plasmodial antigens, possibly a measure of cellular delayed-type hypersensitivity, at times develop as part of successful immune responses to plasmodia (10, 14) and (ii) the demonstrations that potent stimulators of T-cell activity such as BCG infection can at times protect from rodent malaria (7) . VOL. 31, 1981 on November 6, 2017 by guest http://iai.asm.org/ Downloaded from be demonstrable during the development or expression phase of a successful antiplasmodial defense because ongoing systemic T-cell responses generate a signal which in turn causes activation of this macrophage capacity (38, 40) . In a previous study (32) , this proposition was tested using avirulent P. yoelii infection of ICR mice as the experimental model. In contrast with what would be expected if a cellular defense were generated, it was found that animals which successfully eliminated malaria showed defective macrophage microbicidal capacities in liver, spleen, and peritoneal cavity. Thus, the present studies were conducted (i) to further characterize the defects in macrophage microbicidal capacities caused by murine malarial parasites, (ii) to determine the effects of the loss of this macrophage function on the expression of macrophage-dependent cellular defenses to bacterial pathogens, and (iii) to probe the mechanism through which malaria causes the loss of microbicidal capacities.
The present studies show that patent P. yoelii and P. berghei infections cause a loss of macrophage antimicrobial capacity and compromise macrophage-dependent cellular immunity to at least two genera of bacterium, Mycobacterium and Listeria. The demonstration that Yersinia and Salmonella were less well controlled by malarious mice than by normal mice suggests that the cellular defense to these agents might similarly be compromised, although direct evidence of this was not obtained. Although P. yoelii infection markedly affected the pattern of growth of L. monocytogenes, it did not cause a marked change in the localization of an intravenous challenge of L. monocytogenes. This suggests that malaria does not affect the capacity of L. monocytogenes to localize to macrophages, but rather affects the subsequent capacity of macrophages to kill L. monocytogenes. The demonstration that sheep RBC could similarly cause a loss of macrophage microbicidal capacities without altering the capacity of L. monocytogenes to locate in liver (presumably in Kupffer cells [38] ) gives credence to the view that bloodborne heterologous particles can ablate antilisterial capacities of macrophages without affecting the capacity of L. monocytogenes to localize in these cells. Direct evidence of the cellular location of intravenously inoculated L. monocytogenes was not sought in the present studies of malarious mice, but the patterns of localization and growth observed are consistent with those seen by others (35) .
It was found that BCG grew to higher titers in malarious mice than in normal mice and that malaria ablated the capacity of mice immunized against L. monocytogenes to clear a challenge of L. monocytogenes more rapidly than nonimmune controls. This demonstrates that P. yoelii infection can interfere with the expression of specific acquired cellular immunity. It is reasonable, therefore, to ask whether it is the immunologically specific T lymphocytes or the nonspecific macrophage activities which are compromised by malaria. Direct evidence for a compromise in the nonspecific macrophage functions is provided through the data presented in Fig. 5 and 7. The work of others (22) suggests that lymphocytes may also be adversely affected, but the present study does not address this point.
Direct evidence that macrophages are required for the successful acquisition or expression of immunity to malaria in vivo is not available. However, numerous roles could be or have been suggested. In turn, it could be envisioned that a malaria-caused defect in macrophage function might favor the persistence of the parasite. For example, it is established that immunoglobulin G antibodies are in part responsible for immunity to malaria (9, 12) . The knowledge that some immunoglobulin G antibodies are thymus dependent (11, 28, 45) and require macrophages for antigen presentation (13, 49, 52) might be interpreted to suggest that macrophages play a role in the acquisition of antimalarial immunity. Evidence to prove this proposition is not available. However, Weidanz and his co-workers (53, 54) have recently shown that macrophages from spleens of malarious mice are defltient in the presentation of heterologous Tcell-dependent antigens (sheep and horse RBC). Thus, it can be further suggested that malaria might interfere with the process by which protective antimalarial antibody is generated. Again, direct evidence is lacking.
It might also be argued that antibody might act as an opsonin, thereby causing parasites to preferentially accumulate in macrophages. Evidence from in vitro systems (2, 6, 17, 57) supports the view that opsonins develop during the immune response to murine malaria and that these may be directed against not only parasites (6, 16) but also PRBC (17, 48) and normal RBC (48) . In vivo evidence for a protective effect of opsonins, however, is scarce. Green This study was directed specifically to the question of whether or not P. yoelii infection in mice would alter the nonspecific microbicidal function of macrophages so that susceptibility was altered to infection with bacteria, such as L. monocytogenes, in which the microbicidal action of macrophages, normal or activated, is currently generally regarded to be the major mechanism of host defense and acquired immunity (34, 38, 40) . The results were overwhelmingly in favor of malaria-caused nonspecific interference with macrophage function. Moreover, the results suggest some explanations for the failure of this immune mechanism in malaria itself.
Thus, in this study, it was clearly shown that some plasmodial infections may cause a mouse to lose its capacity to kill facultative intracellular bacteria. Because killing of L. monocytogenes in vivo is effected by macrophages (26, 27, 35) , these results strongly support the view that malaria abrogates macrophage microbicidal capacities. Furthermore, the demonstration that L. monocytogenes was killed less effectively in malarious than in control mice during the first 6 to 12 h after bacterial challenge is in agreement with the suggestion that malaria causes macrophages to lose normal preexisting background levels of bactericidal capacity.
Kaye et al. (20) reported previously that mice concurrently infected with P. berghei (NYU-2) and Salmonella typhimurium (strain KK) died more rapidly than mice infected with but one species of parasite. They showed further that the decreased survival time corresponded to a more rapidly progressing S. typhimurium infection and not with a more fulminant malaria or more rapidly developing or severe anemia. It seems probable, therefore, that a malaria-caused defect in macrophage bactericidal capacities, such as that described in these studies, was in part responsible for enhanced S. typhimurium infection in malarious mice. Kaye and co-workers (18, 19) have also shown that hemolysis can cause increased susceptibility to bacterial infection.
The present studies show that the intravenous injection of any of a variety of heterologous particles may cause a loss of preexisting macrophage microbicidal capacities. Thus, it is suggested that, via a similar mechanism, parasites and debris released into the vascular compartment during malaria, and possibly PRBC, may in part cause the defect in macrophage bactericidal activity observed. The results suggest that a very large number of particles must be generated over a 2-week interval if this mechanism of suppression is to explain totally the loss of microbicidal capacities during P. yoelii infection. The possibility that suppression of macrophage bactericidal capacities occurs through mechanisns in addition to particle bombardment should be considered.
Although it is clear that the murine response to plasmodial infections includes the generation of an enlarged population ofphagocytic cells (30, 50, 56) , direct evidence that these cells contribute to the host defense against malaria is sparse. The demonstrations that (i) activation of some phagocyte-dependent functions occurs during malaria (3, 4, 21, 24, 47, 48, 51, 58) , (ii) procedures which cause nonspecific activation ofphagocytes may concomitantly cause nonspecific protection from plasmodial infection (7, 8) , and (iii) manipulations which interfere with phagocyte function potentiate malaria (15) suggest that macrophages might play a protective role. However, other macrophage-dependent capacities are suppressed or lost during malaria (21, 25, 32, 53, 54) . Thus, although it is tempting to speculate that plasmodial infection might subvert those macrophage functions which, if working properly, could contribute to elimination of the parasites, the possibility that macrophages do not directly contribute to the destruction of parasites must be considered. In this case, the changes in their functional capacities observed during malaria may simply reflect a consequence of their role as scavengers of debris.
